z-logo
Premium
Synthesis of [ 3 H]ABT‐518, a matrix metalloproteinase inhibitor (MMPI) labeled in the phenyl rings
Author(s) -
Raja Shirish N.,
Surber Bruce W.,
Du Jia,
Cross Jeffrey L.
Publication year - 2009
Publication title -
journal of labelled compounds and radiopharmaceuticals
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.432
H-Index - 47
eISSN - 1099-1344
pISSN - 0362-4803
DOI - 10.1002/jlcr.1574
Subject(s) - chemistry , yield (engineering) , benzene , matrix metalloproteinase inhibitor , sulfonyl , medicinal chemistry , stereochemistry , organic chemistry , enzyme , metallurgy , materials science , alkyl
A novel matrix metalloproteinase inhibitor, ABT‐518, [ S ‐( R * , R * )]‐ N ‐[1‐(2, 2‐dimethyl‐1,3‐dioxol‐4‐yl)‐2‐[[4‐[4‐(trifluoromethoxy)‐phenoxy]phenyl]sulfonyl]ethyl]‐ N ‐hydroxyformamide, was labeled with tritium in two phenyl rings in a seven‐step synthesis. The overall radiochemical yield of [ 3 H]ABT‐518 in seven steps starting from 1‐(methylsulfonyl)‐4‐[4‐(trifluoromethoxy)phenoxy]benzene was 6.2% with the radiochemical purity of 99.4%. Copyright © 2009 John Wiley & Sons, Ltd.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom